Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OralScan Laboratories, operating as CDx Diagnostics, is a medical diagnostic company specializing in the early detection of precancerous and cancerous lesions. Based in Suffern, New York, the company developed the OralCDx brush biopsy, a computer-assisted system that allows dentists to non-invasively sample suspicious oral spots. The system uses a proprietary neural network-based image processing platform to identify potentially malignant cells that might be missed by traditional visual examination. The company has also expanded its technology to the gastroenterology market with WATS3D, a wide-area transepithelial sampling system for detecting esophageal dysplasia and Barrett's esophagus. OralScan Laboratories' products are designed to provide clinicians with actionable diagnostic data to prevent cancer through early intervention.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OralScan Laboratories.